VASO Corp has announced its annual stockholder meeting, which will take place on December 8, 2026. This meeting is particularly important as it will include the election of two Class III directors, who will serve for a three-year term. The event highlights VASO's commitment to governance and shareholder engagement in the electromedical and electrotherapeutic apparatus sector.

The meeting will be held at 730 Third Avenue, Room 2E, New York, NY, starting at 10:00 A.M. EST. Shareholders of record as of October 14, 2026, are entitled to attend and vote. VASO encourages all stockholders to participate, emphasizing the importance of their votes in shaping the company’s future.

Background

VASO Corp, identified by CIK 0000839087, operates in the electromedical and electrotherapeutic apparatus sector (SIC 3845). The company is listed on the OTC exchange under the ticker VASO. VASO has undergone several name changes in its history, previously known as Vasomedical, Inc. It is classified as a smaller reporting company and a non-accelerated filer.

What the Filing Says

The definitive proxy statement filed on October 29, 2026, outlines the agenda for the upcoming annual meeting. It states, "At the annual meeting, you will be asked to vote on the following matters: Election of two Class III directors, to serve for a three-year term and until their successors are elected and qualify." Additionally, the agenda includes any other matters that may properly come before the meeting.

Impact

This meeting may affect VASO's shareholders, who will have the opportunity to influence the company's governance direction by voting on the election of directors. The outcome could also have implications for VASO's strategic initiatives within the electromedical industry, as strong governance practices are increasingly recognized as vital for corporate success.

What's Next

The filing does not say what happens next, but it indicates that shareholders are urged to vote their shares by various methods, including electronically or by mail. The proxy materials were first mailed to shareholders on or about October 29, 2026, providing ample time for stockholders to prepare for the meeting.